RFK Jr. Says CDC Must More Closely Align With Trump's Agenda
The agency has made numerous critical errors and is likely suffering from a“deeply embedded malaise,” Kennedy said in a Fox News interview Thursday, adding that he's“not surprised” over the current staff upheaval at the CDC.
CDC Director Susan Monarez was ousted by the Trump administration Wednesday after clashing with Kennedy over his critical view of vaccines, people familiar with the matter said. Security personnel were seen escorting the senior leaders who resigned from the Atlanta campus.
The changes underway at the agency could have wide ranging consequences for public health policy in the US and the pharmaceutical industry, which has embraced the development of novel shots to ward off infectious diseases. The CDC scheduled a meeting of its key vaccine panel for September as it plans a review of the shots that are currently the bedrock of the nation's immunization schedules.
Attorneys representing Monarez said that she was being“targeted” because she“refused to rubber-stamp unscientific, reckless directives and fire dedicated health experts.” Following the apparent firing, three other top CDC officials resigned, with some openly condemning Kennedy while doing so.
“Some people should not be working there,” Kennedy said, in response to a question about the resignations.
The HHS secretary, a longtime vaccine critic, has alarmed public health experts by seeking changes at the agency around immunizations. He fired advisers who make recommendations on which shots Americans should get and replaced them with people who questioned their safety.
Kennedy's drug regulators also limited who could get Covid boosters this fall without first speaking to a doctor to those 65 and over or with underlying conditions. Last year, no one over 6 months had to consult with a physician to get a Covid booster.
Medical groups have called Kennedy's tougher stance on vaccines dangerous and have recommended most people still get Covid boosters and other shots.
The upheaval has stoked anxiety among vaccine manufacturers, according to people familiar with the matter, exacerbating fears about further crackdowns. The departure of Demetre Daskalakis, director of the National Center for Immunization and Respiratory Diseases, was particularly alarming, two of the people said, as he had been a reliable point of contact at the increasingly disorganized agency.
It's also drawn the ire of Republican Senator Bill Cassidy of Louisiana, a doctor who voted to confirm Kennedy after getting assurances about the future of immunizations in the US. Cassidy is a member of the Senate Finance Committee, where Kennedy is slated to testify about other issues on Sept. 4, according to people familiar with the discussions.
Kennedy's efforts could have disastrous consequences for the roughly $77 billion global vaccine industry, which has nearly doubled in size since 2019 thanks to demand for shots to prevent Covid infections and the cancer-causing virus HPV, according to the World Health Organization.
In the US, manufacturers have long depended on an established system in which the Food and Drug Administration approves new shots and the CDC issues influential recommendations covering who should get them. Sweeping changes to either agency could discourage investment in vaccine research and lead to fewer new shots in the future.
With assistance from Rachel Cohrs Zhang and Josh Eidelson.
©2025 Bloomberg L.P.
This article was generated from an automated news agency feed without modifications to text.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- United States Lubricants Market Growth Opportunities & Share Dynamics 20252033
- UK Digital Health Market To Reach USD 37.6 Billion By 2033
- Immigration Consultancy Business Plan 2025: What You Need To Get Started
- United States Animal Health Market Size, Industry Trends, Share, Growth And Report 2025-2033
- Latin America Mobile Payment Market To Hit USD 1,688.0 Billion By 2033
- United States Jewelry Market Forecast On Growth & Demand Drivers 20252033
Comments
No comment